PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

48,663 stories, page 55 of 812

Advanced search
🇺🇸Researchonlinelibrary.wiley.comTier 2 · Direct publisher

Ventricular False Tendons and Ventricular Arrhythmias: Distinguishing Incidental Findings From Culprit Substrates

Pacing and Clinical ElectrophysiologyOriginal source
🇩🇪Researchuni-heidelberg.deTier 2 · Direct publisher

Even Dead Tree Branches Move During the Day

Heidelberg UniversityOriginal source
🇺🇸Researchonlinelibrary.wiley.comTier 2 · Direct publisher

Outcomes of Subcutaneous Implantable Cardioverter Defibrillators in Patients Being Considered for Heart Transplantation: A Retrospective Cohort Study

Pacing and Clinical ElectrophysiologyOriginal source
🇩🇪pharma_equipmentsyntegon.comTier 2 · Direct publisher

Saving energy starts with in-depth process analysis

Syntegon (Bosch Packaging)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Guangzhou Baiyunshan Pharmaceutical Q3 Net Profit Down 50.2% Y/Y

TradingViewOriginal source
🇩🇰Associationnovonordiskfonden.dkTier 2 · Direct publisher

European Vaccine Initiative and Novo Nordisk Foundation launch new network to advance mucosal immunity research for airway vaccines: AVANT-guard

Novo Nordisk Foundation (News)Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Shijiazhuang Yiling Pharmaceutical Q3 Net Profit Up 2.04% Y/Y

TradingViewOriginal source
🇩🇪Researchuk-essen.deTier 2 · Direct publisher

Durchbrüche in der Behandlung von Patientinnen und Patienten mit kleinzelligen Lungenkarzinomen und Melanomen – Westdeutsches Tumorzentrum Essen maßgeblich beteiligt

Universitätsklinikum EssenOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services earnings: what to look for from WST

Yahoo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Has The Story Under Krystal Biotech Stock Run Out?

TrefisOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA warns Amgen over cancer drug promotional video

pharma.economictimes.indiatimes.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Anthropic buys Mithril Medicine, a one-person biotech that ran a muscular dystrophy drug programme with Claude

DealroomOriginal source
🇸🇪Researchvgrfokus.seTier 3 · Secondary coverage

Förebyggande aggressionsträning ska hjälpa ungdomar att inte ta till våld

Sahlgrenska SwedenOriginal source
🇫🇷Industryipsen.comTier 1 · Company source

Rare cholestatic liver disease: asking the questions that could change care

Ipsen RSSOriginal source
🇺🇰Industrygsk.comTier 1 · Company source

GSK delivers strong Q3 performance and continued momentum

GSK NewsOriginal source
🌍Industryhealth.ucdavis.eduTier 1 · Company source

Wider surgical margins may not mean better cancer control, finds large-scale treatment trial

UC Davis HealthOriginal source
🌍Industryhealth.ucdavis.eduTier 1 · Company source

UC Davis Health earns Comprehensive Hypertension Center Certification from American Heart Association

UC Davis HealthOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US-based Artiva Halts All Clinical Trials of NK Cell Therapy; GC Cell's Licensing Revenue at Zero as Shares Plunge 19%

BigGo FinanceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

From AI Drug Discovery to Space Biotech: BIX 2026 Opens in Seoul with 300 Companies from 35 Countries

BigGo FinanceOriginal source
🇮🇹Researchhumanitas.itTier 2 · Direct publisher

Una serata speciale al concerto di Ligabue per i giovani del progetto AYA di Humanitas

Humanitas Research HospitalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Danish BioTech Samplix secures €25 million in first close of financing round to scale antibody discovery

EU-StartupsOriginal source
🇮🇹Researchpoliclinico.mi.itTier 2 · Direct publisher

#PASSAPAROLA. [10.11] ADHD: famiglia, scuola e strategie di intervento. Al Policlinico di Milano un incontro aperto a tutti

Policlinico di MilanoOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

[ESMO] K-Bio steps onto global stage for new anticancer drugs, with cancer vaccines and ADCs heading toward Phase 3 trials

더바이오Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech (LEGN) Stock Could Trade Below Its Sales Backdrop

Yahoo FinanceOriginal source
🇨🇭Industryroche.comTier 1 · Company source

Roche strengthens cancer diagnostic portfolio with launch of test for differential diagnosis of mesothelioma

Roche NewsroomOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Safe Drug Disposal

Manhattan Times NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Junshi Biosciences Announces Final Analysis Results of the Phase 3 NEOTORCH Study at ESMO Congress 2026

Macau BusinessOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Oral Mucositis Clinical Trial Pipeline: DelveInsight Highlights Major Advances, Transformative Therapies, and 10+ Leading Players Wheeling the Therapeutics Landscape

StreetInsiderOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech, Inc. Stock 12‑Month Price Target Raised to $409.38, Implies 28% Upside

TradingViewOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Opinion: Biotechs going to market alone must learn to go global

BioSpaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Longevity BioTech Market Outlook 2030: Market Size, CAGR, Trends And Forecast Analysis

The National Law ReviewOriginal source
🇯🇵Researchhosp.tohoku.ac.jpTier 2 · Direct publisher

【10/28放送予定】ミヤギテレビ「ミヤギnews every.」に総合外科 乳腺・内分泌グループ 原田 成美准教授が出演します

Tohoku University HospitalOriginal source
🇯🇵Researchhosp.tohoku.ac.jpTier 2 · Direct publisher

「臨床研究法」に係る不適合事案のご報告と再発防止策について

Tohoku University HospitalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Fosun Pharmaceutical Earnings Buoyed By Extraordinary Gains

ForbesOriginal source
🌍discoverynews.google.comTier 2 · Trade media

ESMO26: Sac-TMT sets survival benchmark in recurrent endometrial cancer

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Scientists Tested an Experimental Baldness Pill on 536 Men. Here’s What Happened.

VICEOriginal source
🌍discoverynews.google.comTier 2 · Trade media

ESMO26: Intismeran sets new benchmark in adjuvant melanoma

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Anthropic Buys a Small Drug Startup as It Pushes Deeper Into Biotech

The InformationOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Building Worcester: New restaurants, nearly $5M in grants and a boost for biotech

The Worcester GuardianOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

San Diego biotech lays off nearly all its staff after drug trial failure and 2 patient deaths

San Diego Union-TribuneOriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Biogen filed Form 10-Q

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

Biogen filed Form 8-K

SEC EDGAROriginal source
🇺🇸Regulatorysec.govTier 1 · Regulatory source

GSK filed Form 6-K

SEC EDGAROriginal source
🌍Researchnature.comTier 2 · Direct publisher

An engineered, compact Cas12m variant for multiplexed gene activation in vivo

Nature BiotechnologyOriginal source
🌍Researchnature.comTier 2 · Direct publisher

An mRNA–lipid nanoparticle vaccine against H5N1 influenza virus protects lactating dairy cows from infection

Nature BiotechnologyOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities: Proposed Collection; Comment Request

This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to requ...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

National Institute on Aging; Notice of Meeting

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Center for Scientific Review; Notice of Closed Meeting

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Individualized Human Genome Editing Products: Considerations for BLA Submission and Postapproval Management; Draft Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft document...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Electronic Submission Template for Investigational Device Exemption (IDE) Applications; Draft Guidance for Sponsors and Food and Drug Administration Staff; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of the draft guidanc...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Health Data, Technology, and Interoperability: ONC Deregulatory Actions To Unleash Prosperity

This final rule focuses on deregulatory actions identified in HHS regulations regarding health infor...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities; Proposed Collection; Comment Request; Application for Participation in Food and Drug Administration Fellowship and Traineeship Programs

The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public commen...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Color Additive Certification

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has b...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities; Proposed Collection; Comment Request; Food and Drug Administration Rapid Response Surveys

The Food and Drug Administration (FDA or Agency) is announcing an opportunity for public comment on...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Issuance of Priority Review Voucher; Rare Pediatric Disease Product; EMCITATE (Tiratricol)

The Food and Drug Administration (FDA) is announcing the issuance of a priority review voucher to th...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Issuance of Priority Review Voucher; Rare Pediatric Disease Product; ATEBRIOZ (Zilurgisertib)

The Food and Drug Administration (FDA) is announcing the issuance of a priority review voucher to th...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Notice of Approval of Product Under Voucher: Material Threat Medical Countermeasure (MCM) Priority Review Voucher; Bixlenvo (Bictegravir and Lenacapavir)

The Food and Drug Administration (FDA) is announcing the approval of a product redeeming a material...

Federal RegisterOriginal source
🇺🇸Regulatoryfederalregister.govTier 1 · Regulatory source

Agency Information Collection Activities; Proposed Collection; Comment Request; Electronic Records; Electronic Signatures

The Food and Drug Administration (FDA, Agency, or we) is announcing an opportunity for public commen...

Federal RegisterOriginal source